Defined Benefit (DB) pension schemes in which the employer bears the investment and longevity risk have been on a downward journey to eventual extinction in the U.K. and many other jurisdictions for years. Extending life spans and low investment returns have combined to make running these schemes far too operationally risky for most employers including many of the largest.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains
The total number of life insurance policies purchased in the life settlement industry’s secondary market…
Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market
New Prudential Regulation Authority consultation paper spells out the new capital charge for funded reinsurance…
Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors
Origination values in the proprietary reverse mortgage market in the US have exceeded the agency-backed…
As PRT Market Grows, Service Providers Look for Ways to Keep Up
Business may be brisk in the UK pension risk transfer market, but human capital constraints…
